Scientific publications

Journal for ImmunoTherapy of Cancer, 2026

CSF proteomics identifies ADGRG1 as a predictive biomarker of intrathecal immune checkpoint inhibitor response in leptomeningeal metastasis

Wang L., Yang G., Lei H. et al.

Pulmonary Circulation, 2026

Plasma GDF‐15 and PSP‐D Predict the Development of Pulmonary Arterial Hypertension in Systemic Sclerosis

Engel Sällberg A., Ahmed S., Ahmed A. et al.

Frontiers in Psychiatry, 2026

Olink proteomics identifies FGF-19 as a treatment-responsive inflammatory biomarker associated with acupuncture intervention in young females with mild depression

Li Z., Jiao Z., Peng M. et al.

Frontiers in Psychiatry, 2026

Olink proteomics identifies FGF-19 as a treatment-responsive inflammatory biomarker associated with acupuncture intervention in young females with mild depression

Li Z., Jiao Z., Peng M. et al.

Science Translational Medicine, 2026

AAV8 gene therapy and dietary insults together precipitate cholestatic liver disease in a mouse model of X-linked myotubular myopathy

Pannia E., Simonian R., Sabha N. et al.

PROTEOMICS – Clinical Applications, 2026

A Network‐Based Association of IBD and Colorectal Cancer Using Proteomics Data

Dhami J., Radhakrishnan S., Russ D. et al.

The Journal of Maternal-Fetal & Neonatal Medicine, 2026

Causal relationship between 91 inflammatory factors and fetal growth restriction: a bidirectional Mendelian randomization study

Shen J., Chen X., Fang R. et al.

npj Breast Cancer, 2026

Phase II trial of anlotinib-chemotherapy combination in pretreated HER2-negative metastatic breast cancer: therapeutic efficacy and proteomic biomarker profiling

Xu T., Gu Q., Li S. et al.

Alzheimer's & Dementia, 2026

Ethnic‐specific effects of the LILRB2–LILRB5 locus and newly identified risk loci for Alzheimer's disease in the East Asian population

Cao H., Zheng Z., Zhou X. et al.

Journal of Advanced Research, 2026

Tocilizumab-loaded nanoparticles block IL-6R and reduce edema after intracerebral hemorrhage

Ma S., Lin Q., Xue D. et al.

Nature Communications, 2026

LOAd703-induced tumor microenvironment gene engineering in combination with atezolizumab in metastatic malignant melanoma: a phase I/II trial

Hamid O., Ekström-Rydén V., Mehmi I. et al.

Nature Medicine, 2026

A quantitative DOPA decarboxylase biomarker for diagnosis in Lewy body disorders

Bolsewig K., Bellomo G., Hok-A-Hin Y. et al.

Journal of Pediatric Gastroenterology and Nutrition, 2026

A novel diagnostic serum protein signature for pediatric inflammatory bowel disease

Mathisen C., Nyström N., Bazov I. et al.

Journal of Parkinson’s Disease, 2026

A monoclonal antibody-based immunoassay reinforces DOPA decarboxylase in cerebrospinal fluid as a diagnostic biomarker for Parkinson's disease with potential prognostic value

Aviolat H., Mollon J., Giaisi S. et al.

iScience, 2026

Association between elevated expression of GDF15/GFRAL and sarcopenia risk

Zhang Z., Fan P., Zhang W. et al.

Experimental Gerontology, 2026

Therapeutic potential of Cistanche against Parkinson's disease via regulating circulating inflammation: Insights from Mendelian randomization, molecular docking, and in vivo studies

Liu H., Chen Y., Li C. et al.

Clinical Rheumatology, 2026

Cartilage metabolism mediates the association between serum vitamin D levels and the risk of osteoarthritis: a prospective cohort study from the UK Biobank

Wang J., Cheng X., Wang J. et al.

Cardiovascular Diabetology, 2026

Proteomics-derived organ-specific aging clusters predict macrovascular and microvascular complications in diabetes

Yuan S., Lin Z., Song Y. et al.

MedComm, 2026

Hemidesmosome Mutations Contribute to the Onset and Severity of Acquired Autoimmune Bullous Diseases

Cao S., Wang T., Lv C. et al.

Scandinavian Journal of Clinical and Laboratory Investigation, 2026

Effect of a standardized meal on inflammatory biomarkers

Dencker M., Björgell O., Hlebowicz J.